The ethics of clinical research in the Third World.

@article{Angell1997TheEO,
  title={The ethics of clinical research in the Third World.},
  author={Marcia Angell},
  journal={The New England journal of medicine},
  year={1997},
  volume={337 12},
  pages={
          847-9
        }
}
  • M. Angell
  • Published 1997
  • Medicine
  • The New England journal of medicine
An essential ethical condition for a randomized clinical trial comparing two treatments for a disease is that there be no good reason for thinking one is better than the other.1,2 Usually, investigators hope and even expect that the new treatment will be better, but there should not be solid evidence one way or the other. If there is, not only would the trial be scientifically redundant, but the investigators would be guilty of knowingly giving inferior treatment to some participants in the… Expand
The ethical problems with sham surgery in clinical research.
  • R. Macklin
  • Medicine
  • The New England journal of medicine
  • 1999
TLDR
The recent use of sham surgery in randomized, controlled trials raises three critical questions about research involving human subjects that points to ongoing uncertainties and disagreements in assessing the risks and benefits of research protocols. Expand
Placebo-Controlled Trials, Ethics of
TLDR
The article describes different positions on placebo use in trials in low- and middle-income countries where study participants may not have had access to an established effective treatment outside the trial. Expand
Ethics in clinical research: searching for absolutes.
  • K. Joseph
  • Medicine
  • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 1998
TLDR
It is clear that there is a need for increased patient participation in any attempt to achieve consensus on the ethical conduct of medical research, and some recent controversies that highlight the fractious nature of the debate are reviewed. Expand
Cross-Cultural Considerations in Medical Ethics
TLDR
It is argued that research on human subjects is best conducted within the sponsoring country and, further, that in all cases researchers have a responsibility not to leave any human subjects with deadly diseases untreated if they have the means to treat them. Expand
Using empirical data to inform the ethical evaluation of placebo controlled trials
TLDR
Using some published research concerning the use of placebo-controls in clinical research in hypertension and psychiatric drug trials, it is suggested some ways that such data might be incorporated into the ethical analysis concerning placebo use in clinical trials. Expand
Two-tiered health care: the root of ethical problems in recent clinical trials.
  • T. Brewer, S. J. Heymann
  • Medicine
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • 1998
TLDR
The ethics of clinical trials involving patients with infectious diseases has received a great deal of attention recently in both the lay and the scientific press, and the accompanying editorial raised ethical concerns about a placebo-controlled tuberculosis (TB) prevention study. Expand
Clinical trials and SCID row: the ethics of phase 1 trials in the developing world.
TLDR
It is argued that interest in conducting translational research in the developing world, particularly in the context of hemophilia trials, should motivate more rigorous ethical thinking around clinical trials involving economically disadvantaged populations. Expand
The ethics of clinical research in developing countries.
TLDR
Critics of the placebo-controlled design argue that it is unacceptable to treat a patient involved in a research protocol differently, depending solely on whether he is from the north or the south; this means no zidovudine for pregnant HIV-positive women in all poor countries. Expand
Ethical issues in the design and conduct of clinical trials in developing countries.
TLDR
Ethical issues in the design and conduct of clinical trials in developing countries are discussed, focusing on phase 3 and other drug trials that, if successful, can lead to the use of drugs in these countries. Expand
Ethical Issues with Clinical Trials in Developing Countries
In recent years, the increasingly global nature of health research and the conduct of clinical trials involving human participants have highlighted a number of new ethical issues. This often happensExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Equipoise and the ethics of clinical research.
  • B. Freedman
  • Medicine
  • The New England journal of medicine
  • 1987
TLDR
An alternative concept of equipoise is suggested, which would be based on present or imminent controversy in the clinical community over the preferred treatment, which is satisfied if there is genuine uncertainty within the expert medical community--not necessarily on the part of the individual investigator--about the preferredreatment. Expand
The ethical problems with sham surgery in clinical research.
  • R. Macklin
  • Medicine
  • The New England journal of medicine
  • 1999
TLDR
The recent use of sham surgery in randomized, controlled trials raises three critical questions about research involving human subjects that points to ongoing uncertainties and disagreements in assessing the risks and benefits of research protocols. Expand
Proposed revisions to the Declaration of Helsinki--will they weaken the ethical principles underlying human research?
  • T. Brennan
  • Medicine
  • The New England journal of medicine
  • 1999
TLDR
A proposed protocol involving an analysis of human immunodeficiency virus (HIV) infection in pregnant women and subsequent follow-up of their offspring in rural areas of a country in sub-Saharan Africa and some members of the committee thought that the proposed protocol was ethically suspect. Expand
Ethics and international research
TLDR
A recent commentary in the New England Journal of Medicine criticised placebo controlled trials designed to identify simple and effective interventions to prevent maternal-infant HIV transmission in developing countries and proposed that studies supported by the United States government should provide all participants with the same level of care that is available to Americans. Expand
Ethical complexities of conducting research in developing countries.
TLDR
The current debate hinges on the morality of using a placebo control when the AIDS Clinical Trials Group protocol 076 is being effectively used in other parts of the world and the most compelling response to criticisms of the placebo-control test designs is that it provides definitive answers to safety and effectiveness questions in the study setting. Expand
International ethical guidelines for biomedical research involving human subjects
TLDR
This is a very seriously written book which is, incidentally, beautifully edited and well produced and it is essentially for educationists and community physicians who will follow the discussions with interest and benefit. Expand
The need to revise the Declaration of Helsinki.
  • R. Levine
  • Medicine
  • The New England journal of medicine
  • 1999
The Declaration of Helsinki requires revision because it is defective in two important respects. First, it relies on a distinction between therapeutic and nontherapeutic research; all documents thatExpand
Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths
  • B. Freedman, C. Weijer, K. Glass
  • Medicine
  • The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
  • 1996
TLDR
The case against placebos is presented in a compendious form that takes account of scientific and statistical as well as normative issues, and many previous criticisms of the use of placebo had focused on the violence it does to truth-telling. Expand
Ethical imperialism? Ethics in international collaborative clinical research.
  • M. Angell
  • Medicine
  • The New England journal of medicine
  • 1988
TLDR
When you read more every page of this ethical imperialism ethics in international collaborative clinical research, what you will obtain is something great. Expand
Patients' preferences in randomized clinical trials.
  • M. Angell
  • Medicine
  • The New England journal of medicine
  • 1984
TLDR
The results of a questionnaire study of why participating physicians entered so few of their eligible patients into the NSABP trial found a low rate of accrual. Expand
...
1
2
3
4
5
...